Cargando…
Identification of Surface Antigens That Define Human Pluripotent Stem Cell-Derived PRRX1+Limb-Bud-like Mesenchymal Cells
Stem cell-based therapies and experimental methods rely on efficient induction of human pluripotent stem cells (hPSCs). During limb development, the lateral plate mesoderm (LPM) produces limb-bud mesenchymal (LBM) cells that differentiate into osteochondroprogenitor cells and form cartilage tissues...
Autores principales: | Yamada, Daisuke, Takao, Tomoka, Nakamura, Masahiro, Kitano, Toki, Nakata, Eiji, Takarada, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910499/ https://www.ncbi.nlm.nih.gov/pubmed/35269809 http://dx.doi.org/10.3390/ijms23052661 |
Ejemplares similares
-
A protocol to induce expandable limb-bud mesenchymal cells from human pluripotent stem cells
por: Takao, Tomoka, et al.
Publicado: (2022) -
A novel chondrocyte sheet fabrication using human-induced pluripotent stem cell-derived expandable limb-bud mesenchymal cells
por: Takao, Tomoka, et al.
Publicado: (2023) -
PRRX1 promotes malignant properties in human osteosarcoma
por: Joko, Ryoji, et al.
Publicado: (2020) -
Establishment of a human pluripotent stem cell-derived MKX-td Tomato reporter system
por: Fujisawa, Yuki, et al.
Publicado: (2022) -
The Prrx1 limb enhancer marks an adult subpopulation of injury-responsive dermal fibroblasts
por: Currie, Joshua D., et al.
Publicado: (2019)